- Report
- September 2022
- 271 Pages
Global
From €3266EUR$3,600USD£2,815GBP
- Report
- September 2022
- 417 Pages
Global
From €3266EUR$3,600USD£2,815GBP
- Report
- May 2022
- 140 Pages
Global
From €3266EUR$3,600USD£2,815GBP
- Report
- January 2022
- 193 Pages
Global
From €3266EUR$3,600USD£2,815GBP
- Report
- July 2025
- 88 Pages
Global
From €3500EUR$4,133USD£3,122GBP
- Report
- March 2025
- 138 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- May 2025
- 150 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 150 Pages
Australia
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 150 Pages
Canada
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 150 Pages
Italy
From €4400EUR$4,850USD£3,792GBP
- Report
- April 2026
- 150 Pages
United Kingdom
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 193 Pages
Canada
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 202 Pages
China
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 194 Pages
Germany
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 170 Pages
Canada
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 172 Pages
Germany
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 344 Pages
Canada
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 210 Pages
India
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 211 Pages
India
From €4400EUR$4,850USD£3,792GBP
- Report
- March 2026
- 209 Pages
Germany
From €4400EUR$4,850USD£3,792GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more